Hua Medicine, Chunlai Education kick off HK flotations
Biotechnology firm Hua Medicine has launched bookbuilding for its Hong Kong IPO, targeting up to HK$972.1m ($123.9m) in proceeds.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts